Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Hernia ; 25(6): 1715-1725, 2021 12.
Article in English | MEDLINE | ID: mdl-33797679

ABSTRACT

INTRODUCTION: Establishing straightforward and reproducible steps to describe the technique performed with the aid of the robotic system for complex hernia surgery is key for good outcomes. Even using the description of open surgery as a parameter for performing the robotic technique, it is important to stress the particularities of this access. To describe the steps to perform robotic-assisted TAR (r-TAR) in a standardized technique, with a critical and safe view of all the anatomical structures. DESCRIPTION OF THE TECHNIQUE: We defined 8 landmarks for the critical view of safety in r-TAR which include: (1) patient position, trocar and docking; (2) posterior rectus sheath mobilization; (3) transversus abdominis release (TAR)-Top-down technique; (4) transversus abdominis release (TAR)-bottom-up technique and mesh insertion; (5) contralateral trocar insertion and redocking, 6) posterior sheath closure; (7) final mesh positioning; and (8) anterior defect closure and drains. DISCUSSION: Complex hernia surgery using a robotic-assisted posterior component separation requires well-established steps so the procedure can be reproducible and achieve better results.


Subject(s)
Abdominal Wall , Hernia, Ventral , Robotic Surgical Procedures , Abdominal Muscles/surgery , Abdominal Wall/surgery , Hernia, Ventral/surgery , Herniorrhaphy/methods , Humans , Robotic Surgical Procedures/methods , Surgical Mesh
2.
Hernia ; 22(6): 897-898, 2018 12.
Article in English | MEDLINE | ID: mdl-30306367
4.
Hernia ; 22(4): 637-644, 2018 08.
Article in English | MEDLINE | ID: mdl-29713832

ABSTRACT

PURPOSE: Posterior component separation (PCS) via the transversus abdominis release (TAR) procedure continues to gain popularity. However, neither the physiologic basis nor the extent of myofascial medialization after TAR is established. We aimed to assess both anterior and posterior rectus fascia (AF and PF) medialization following each step of the TAR procedure. METHODS: Ten fresh cadavers underwent PCS via TAR. Steps included midline laparotomy (MLL), retrorectus dissection (RRD), incision of the posterior rectus sheath (IPL), transversus abdominis muscle division (TAD), and retromuscular dissection (RMD). Medial advancement of AF and PF was measured following application of 2.5, 5.0 lb, and maximal tension to the fascial edge. Values are represented as mean advancement past midline in centimeters. RESULTS: MLL allowed advancement of 2.5, 3.7, and 4.9 cm. RRD provided advancement of 4.1, 5.9, and 7.6 cm for AF and 4.4, 6.2, and 7.5 cm for PF. IPL provided advancement of 4.2, 6.1, and 8.0 cm for AF and 4.6, 6.6, and 8.3 cm for PF. TAD provided advancement of 4.5, 6.6, and 8.6 cm for AF and 5.3, 7.5, and 9.5 cm for PF. RMD provided advancement of 5.5, 7.9, and 9.9 cm for AF and 6.9, 9.6, and 11.2 cm for PF. Overall, the complete TAR procedure provided AF advancement of 102% and PF advancement of 129%, over baseline. CONCLUSIONS: The TAR procedure provides for substantial medial advancement of both anterior and posterior myofascial components of the abdominal wall. Retromuscular dissection deep to the divided transversus abdominis muscle appears to be the key step of the procedure, allowing for effective reconstruction of very wide (≈ 20 cm) defects.


Subject(s)
Abdominal Muscles/surgery , Hernia, Ventral/surgery , Herniorrhaphy/methods , Abdominal Wall/surgery , Cadaver , Dissection/methods , Fascia , Female , Humans , Laparotomy , Male
5.
Hernia ; 22(2): 303-309, 2018 04.
Article in English | MEDLINE | ID: mdl-29349616

ABSTRACT

BACKGROUND: A minority of patients undergoing posterior component separation (PCS) have abdominal wall defects that preclude complete reconstruction of the visceral sac with native tissue. The use of absorbable mesh bridges (AMB) to span such defects has not been established. We hypothesized that AMB use during posterior sheath closure of PCS is safe and provides favorable outcomes. METHODS: We performed a retrospective review of consecutive patients undergoing PCS with AMB at two hernia centers. Main outcome measures included demographics, comorbidities, and post-operative complications. RESULTS: 36 patients were identified. Post-operative wound complications included five surgical site infections. At a median of 27 months, there were five recurrent hernias (13.9%), 2 of which were parastomal, but no episodes of intestinal obstruction/fistula. CONCLUSIONS: Utilization of AMB for large posterior layer deficits results in acceptable rates of perioperative wound morbidity, effective PCS repairs, and does not increase intestinal morbidity or fistula formation.


Subject(s)
Abdominal Muscles , Abdominal Wound Closure Techniques , Absorbable Implants , Herniorrhaphy , Intestinal Fistula , Surgical Mesh , Abdominal Muscles/injuries , Abdominal Muscles/surgery , Abdominal Wound Closure Techniques/adverse effects , Abdominal Wound Closure Techniques/instrumentation , Adult , Aged , Female , Hernia, Ventral/surgery , Herniorrhaphy/adverse effects , Herniorrhaphy/instrumentation , Herniorrhaphy/methods , Humans , Intestinal Fistula/epidemiology , Intestinal Fistula/etiology , Male , Middle Aged , Outcome and Process Assessment, Health Care , Recurrence , Retrospective Studies , Surgical Wound Infection/epidemiology , Surgical Wound Infection/etiology , Treatment Outcome , United States/epidemiology
6.
Hernia ; 22(2): 363-369, 2018 04.
Article in English | MEDLINE | ID: mdl-29247364

ABSTRACT

INTRODUCTION: Traumatic flank hernias (TFH) are caused by a blunt abdominal trauma with resultant detachment of the oblique musculofascial complex at the iliac crest and/or costal margin. Given such proximity to the bony structures and essential absence of healthy fascia to anchor the mesh, TFH represent a challenging surgical problem. Although laparoscopic repair of ventral hernias has become very common, no series of laparoscopic repairs of TFH has been reported to date. We present a series of patients undergoing laparoscopic repair of TFH. METHODS: After retrospective review of prospective hernia database at two Hernia centers, patients undergoing laparoscopic TFH repair were identified and analyzed. Main outcome measures included patient demographics, surgical technique, intraoperative data, and post-operative outcomes. RESULTS: From December 2007 to December 2013, 14 patients underwent laparoscopic repair of a TFH. Eleven patients had chronically incarcerated viscera within the defect. Operative steps included complete reduction of the hernia sac, pre/retroperitoneal dissection to expose the entire lateral edge of a psoas muscle, defect closure with transabdominal sutures, wide mesh overlap, and transabdominal suture fixation with selective use of bone anchors. The mean operative time was 174 min (range 125-230). Mean estimated blood loss was 65 cc. Mean mesh size was 295 cm2. There were no peri-operative complications. Mean hospital stay was 3.1 days and all patients returned to full activities by 6 weeks. At a mean follow-up of 35 months, there have been no recurrences. CONCLUSION: Laparoscopic approach to TFH is feasible and safe. It is associated with minimal hospital stay and fast functional recovery. The key components of our approach include wide pre/retroperitoneal with defect closure and subsequent wide mesh underlay coverage with fixation to bony structures using anchors/screws. We believe that the laparoscopic approach should safely considered for the majority of patients with TFH.


Subject(s)
Abdominal Injuries/complications , Abdominal Wound Closure Techniques/adverse effects , Hernia, Abdominal , Herniorrhaphy , Laparoscopy , Wounds, Nonpenetrating/complications , Adult , Female , Hernia, Abdominal/epidemiology , Hernia, Abdominal/etiology , Hernia, Abdominal/surgery , Herniorrhaphy/adverse effects , Herniorrhaphy/instrumentation , Herniorrhaphy/methods , Humans , Incidence , Laparoscopy/adverse effects , Laparoscopy/instrumentation , Laparoscopy/methods , Male , Outcome Assessment, Health Care , Recurrence , Retrospective Studies , United States
8.
Hernia ; 20(2): 289-95, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26886013

ABSTRACT

BACKGROUND: Posterior component separation has become a common approach to complex abdominal wall reconstructions. This technique includes creation of an extraperitoneal retromuscular space for subsequent large synthetic mesh reinforcement. In certain cases, when complete restoration of "posterior" layer is precluded by significant tissue loss/damage, one proposed strategy is to replace the posterior fascia with an absorbable synthetic polyglactin (Vicryl) mesh. However, the safety of this strategy to prevent mesh-related visceral complication is unknown. Herein, we aimed to characterize mesh-viscera adhesion profiles and host tissue response of synthetic mesh either exposed directly to the viscera, or protected with Vicryl mesh. METHODS: Using adult Yorkshire pigs, 5 × 5 cm pieces of mesh were secured to the intact peritoneum in each of the four quadrants (n = 6 pigs, 24 mesh samples). The study groups were Vicryl (V), Marlex (M), Softmesh (S), Marlex + Vicryl construct (MV), Softmesh + Vicryl construct (SV). The self-made composite meshes were then implanted with the Vicryl side facing the exposed viscera. The pigs were survived for 60 days. At necropsy, grossly, the extent and tenacity of visceral adhesions were evaluated using established scales. Histologically, all specimens for fibrous encapsulation on the visceral surface of the mesh were reviewed by an experienced pathologist blind to meshes used. RESULTS: At necropsy, all Vicryl meshes were completely resorbed. The mean adhesion and tenacity scores for M and MV were 1.8 and 1.1 (P > 0.05), 2.0 and 1.5 (P > 0.05), respectively; while the mean adhesion extent scores and tenacity scores for S and SV were 2.0 and 1.2 (P > 0.05), 2.0 and 1.7 (P > 0.05). No significant difference in adhesion extent and tenacity was observed between Synthetic and Vicryl composite mesh groups. Histologically, Marlex + Vicryl mesh and Softmesh + Vicryl mesh constructs had thicker fibrous capsules than the corresponding unprotected Marlex and Soft mesh implants. Furthermore, visceral adhesions in the composite groups were noted to be to the fibrous capsule and not synthetic mesh itself. CONCLUSION: Utilization of the absorbable polyglactin (Vicryl) mesh as a separating layer between a synthetic mesh and intestines, did not reduce adhesions across various mesh types and composites. Histologically, however, a thick fibrous capsule replaced the Vicryl mesh and may be an important layer to prevent intestinal erosion into retromuscular synthetic meshes.


Subject(s)
Peritoneum/surgery , Surgical Mesh , Tissue Adhesions/pathology , Animals , Biocompatible Materials , Female , Models, Animal , Peritoneum/pathology , Polyglactin 910 , Prosthesis Implantation , Swine , Tissue Adhesions/etiology
13.
Hernia ; 19 Suppl 1: S355, 2015 Apr.
Article in English | MEDLINE | ID: mdl-26518846
15.
Hernia ; 19(3): 465-72, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25854510

ABSTRACT

INTRODUCTION: Prosthetic reinforcement is a critical component of hernia repair. For massive defects, mesh overlap is often limited by the dimensions of commercially available implants. In scenarios where larger mesh prosthetics are required for adequate reinforcement, it may be necessary to join several pieces of mesh together using non-absorbable suture. Here, we report our outcomes for abdominal wall reconstructions in which "quilted" mesh was utilized for fascial reinforcement. METHODS: Patients undergoing open incisional hernia repair utilizing posterior component separation and transversus abdominis muscle release, with use of quilted synthetic mesh placed in the retromuscular position, were reviewed. Main outcome measures included patient, hernia, and operative characteristics and post-operative outcomes, including surgical site occurrence (SSO), surgical site infection (SSI), and recurrence. RESULTS: Thirty-two patients (mean age 55.7 ± 9.3, BMI 38.3 ± 5.8 kg/m(2)) underwent open ventral hernia repair with "quilted" mesh placed in the retromuscular position. The mean defect area was 760.1 ± 311.0 cm(2) with a mean width of 24.7 ± 6.4 cm. Quilted meshes consisted of two-piece (69 %), three-piece (19 %) and four-piece (12 %) configurations. Wound morbidity consisted of eight (25 %) SSOs, including four (13 %) SSIs, all of which resolved without mesh excision. With mean follow-up of 9.0 ± 13.6 months, there were two (6.3 %) lateral recurrences, both unassociated with mesh-to-mesh suture line failure. CONCLUSIONS: Massive ventral hernias that require giant mesh prosthetics, currently not commercially available, may be successfully repaired using multiple mesh pieces sewn together in a quilt-like fashion. Such retromuscular repairs are durable, without added morbidity due to the mesh-to-mesh suture line. However, additional operative time is required for quilting the mesh together, prompting strong calls for manufacturing of larger mesh prosthetics.


Subject(s)
Hernia, Ventral/surgery , Herniorrhaphy/methods , Surgical Mesh , Abdominal Wall/surgery , Aged , Databases, Factual , Fasciotomy , Female , Humans , Male , Middle Aged , Retrospective Studies , Surgical Wound Infection/epidemiology
16.
Hernia ; 19(2): 285-91, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25537570

ABSTRACT

PURPOSE: Anterior component separation (ACS) with external oblique release for ventral hernia repair has a recurrence rate up to 32%. Hernia recurrence after prior ACS represents a complex surgical challenge. In this context, we report our experience utilizing posterior component separation with transversus abdominis muscle release (PCS/TAR) and retromuscular mesh reinforcement. METHODS: Patients with a history of recurrent hernia following ACS repaired with PCS/TAR were retrospectively identified from prospective databases collected at two large academic institutions. Patient demographics, hernia characteristics (using CT scan) and outcomes were evaluated. RESULTS: Twenty-nine patients with a history of ACS developed 22 (76%) midline, 3 (10%) lateral and 4 (14%) concomitant recurrences. Contamination was present in 11 (38%) of cases. All were repaired utilizing a PCS/TAR with retromuscular mesh placement (83% synthetic, 17% biologic) and fascial closure. Wound morbidity consisted of 13 (45%) surgical site occurrences including 8 (28%) surgical site infections. Five (17%) patients required 90-day readmission, and two (7%) were related to wound morbidity. One organ space infection with frank spillage of stool resulted in the only instance of mesh excision. This case also represents the only instance of recurrence (3%) with a mean follow-up of 11 (range 3-36) months. CONCLUSION: Patients with a history of an ACS who develop a recurrence represent a challenging clinical scenario with limited options for surgical repair. A PCS/TAR hernia repair achieves acceptable outcomes and may in fact be the best approach available.


Subject(s)
Abdominal Muscles/surgery , Hernia, Ventral/surgery , Herniorrhaphy/methods , Aged , Female , Humans , Male , Middle Aged , Recurrence , Retrospective Studies , Surgical Mesh , Treatment Outcome
17.
Hernia ; 19(1): 155-9, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24659227

ABSTRACT

INTRODUCTION: Uncoated, lightweight, macroporous,monofilament mesh has been shown to demonstrate improved bacterial clearance, better tissue integration,reduced foreign body response, and less chronic pain with equivalent durability for hernia repair. These findings led us to use a new lightweight monofilament polyester mesh (Parietex TCM, Covidien). Here, we report our experience with this mesh in open incisional hernia repair. METHODS: Patients undergoing incisional hernia repair with Parietex TCM were retrospectively identified within our prospectively maintained database. Patient demographics,operative characteristics, and follow-up were reviewed. Outcome parameters included 90-day wound morbidity and hernia recurrence. RESULTS: In 2011, 36 patients (mean age 56.8; mean BMI32.4 kg/m2) underwent open incisional hernia repair with retrorectus mesh placement by two surgeons (MJR, YWN) at Case Medical Center. Anterior and posterior fascial closure was achieved in all cases. Wound morbidity included seven surgical site occurrences: four superficial infections that resolved with antibiotics, one wound dehiscence requiring wet-to-dry packing, and two seromas that resolved without intervention. With a mean follow-up of 13 months, 8 (22%) recurrences have occurred. On reoperation, 7 (19%) of these patients had mechanical failure or fracturing of the mesh. No confounding variables were identified by univariate analysis of patient demographics,operative characteristics, or wound morbidity. CONCLUSION: Lightweight monofilament polyester mesh (Parietex TCM) appears to have a high incidence of mechanical failure in the context of open incisional hernia repair. While this limitation may ultimately be revealed asa weakness of all lightweight mesh, surgeons should be aware that these failures have already been documented.


Subject(s)
Hernia, Ventral/surgery , Herniorrhaphy/adverse effects , Surgical Mesh/adverse effects , Aged , Biocompatible Materials , Female , Humans , Male , Middle Aged , Polyesters , Prosthesis Failure , Prosthesis Implantation/adverse effects , Recurrence , Retrospective Studies
18.
Hernia ; 19(4): 645-50, 2015 Aug.
Article in English | MEDLINE | ID: mdl-24728835

ABSTRACT

PURPOSE: Losartan, a commonly used angiotensin II receptor blocker (ARB) for blood pressure control, also impairs cutaneous wound healing. Our current study will analyze how Losartan affects wound healing in the muscle and fascia from both biomechanical and histological aspects. METHODS: A total of 26 Sprague-Dawley rats were separated into one control group (NS, N = 13) and one experimental group (LG, N = 13) to receive normal saline and 40 mg/kg of Losartan by way of gastric lavage, respectively. 7 days later, all animals were subjected to a 5 cm midline laparotomy. The fascia and skin were then closed with 4-0 prolene and 5-0 vicryl. 15 days postoperatively, the animals were sacrificed and the abdominal wall harvested for wound tensiometric test and histological analysis. RESULTS: All 26 rats survived to the time of necropsy. Tensiometry detected significantly higher wound tensile strength in the NS group (1.6 ± 0.31 N/mm) than in the LG (1.3 ± 0.28 N/mm) group (p = 0.016). Transection histology with trichrome staining demonstrated higher degree of immature fibroplasia inside the wound in the LG group than in the NS group (p = <0.0001). The LG group also had larger incisional gaps than the NG group. CONCLUSION: The antihypertensive drug, Losartan, retards wound healing in the abdominal fascia and reduces wound tensile strength in our rat model. Attention should be paid to the potential effects of various medications on fascial wound healing to guarantee optimal surgical outcomes.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/adverse effects , Fascia/drug effects , Losartan/adverse effects , Wound Healing/drug effects , Abdominal Muscles/drug effects , Abdominal Wall/surgery , Animals , Disease Models, Animal , Fasciotomy , Laparotomy , Male , Rats , Rats, Sprague-Dawley , Tensile Strength/drug effects , Wound Healing/physiology
19.
Hernia ; 18(5): 625-30, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25038895

ABSTRACT

BACKGROUND: Complex hernia repairs represent a formidable surgical challenge. Several comprehensive hernia centers, including ours, with advanced expertise have recently emerged across the country. However, the effects of tertiary specialization remain largely unclear. We aimed to evaluate the impact of developing a comprehensive hernia center on the referral patterns and costs of patients with complex hernias. METHODS: A prospectively maintained database was used to identify all patients undergoing open ventral hernia repair (VHR) between 2006 and 2013 at the Case Comprehensive Hernia Center. Patients were separated into two groups by zip code: those traveling either <25 or >100 miles. Demographics, operative characteristics, length of stay and costs data were analyzed. RESULTS: Of all patients who underwent open VHR during the study period, 287 met the inclusion criteria. Hernia length, width and area were all significantly larger for patients traveling >100 miles (P < 0.01 for all). These patients were also more likely to have active mesh infections (OR 3.57) and non-healing wounds (OR 5.00) when compared with local patients. Length of hospital stay was significantly longer for patients traveling >100 miles compared to those traveling <25 miles (9.7 vs. 6.8; P < 0.0001). Surgical site occurrence, infection and hernia recurrence rates were similar between the two groups during the follow-up period. Patients who traveled >100 miles incurred significantly higher fixed direct and variable direct costs compared to those who traveled <25 miles (P < 0.05 for both). CONCLUSION: The development of a comprehensive hernia center results in centralization of complex hernia care. Patients traveling >100 miles for ventral hernia repair have significantly larger and more complex hernias. The implications for improved patient outcomes and potential reimbursement issues for providing this care should be carefully evaluated.


Subject(s)
Health Facilities/economics , Hernia, Ventral/economics , Hernia, Ventral/surgery , Herniorrhaphy/economics , Referral and Consultation/statistics & numerical data , Adult , Aged , Aged, 80 and over , Costs and Cost Analysis , Databases, Factual , Female , Health Facilities/statistics & numerical data , Humans , Male , Middle Aged , Ohio/epidemiology , Young Adult
20.
Hernia ; 18(1): 65-70, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23329253

ABSTRACT

PURPOSE: A history of methicillin-resistant Staphylococcus aureus (MRSA) surgical site infection presents a significant surgical dilemma as to the risk of subsequent mesh infection, even if no active infection is present. We investigated the outcomes of ventral hernia repair with synthetic mesh in patients with prior MRSA surgical site infections (SSIs). METHODS: All patients with a clean wound but prior MRSA SSI undergoing open ventral hernia repair with mesh by a single surgeon over a 3-year period were reviewed for the development of any major (need for readmission, operative debridement, or mesh removal) or minor SSI. All patients received peri-operative intravenous vancomycin and prolonged suppressive oral trimethoprim/sulfamethoxazole or doxycycline. RESULTS: Ten patients (male = 7, female = 3) with clean wounds and a history of MRSA SSI underwent open ventral hernia repair with retrorectus synthetic mesh placement. Mean follow-up was 13.5 ± 3.3 months. Overall, two patients (20 %) developed SSIs (minor = 2, major = 0). Both SSIs were successfully managed with therapeutic oral antibiotics and local wound care without need for surgical debridement or mesh removal. There have been no hernia recurrences in any of the patients. CONCLUSIONS: Preliminary results suggest that history of MRSA infection may not be a contraindication to the use of synthetic mesh for ventral hernia repair. Macroporous lightweight meshes, combined with use of prolonged suppressive antibiotics and sublay retromuscular mesh placement that provides complete tissue coverage, should be further investigated as an acceptable prosthetic choice when planning a complex ventral hernia repair in the setting of prior MRSA SSI.


Subject(s)
Antibiotic Prophylaxis , Hernia, Ventral/surgery , Herniorrhaphy/methods , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/microbiology , Surgical Mesh , Surgical Wound Infection/microbiology , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Contraindications , Debridement , Device Removal , Doxycycline/therapeutic use , Female , Humans , Male , Middle Aged , Patient Readmission , Retrospective Studies , Staphylococcal Infections/drug therapy , Staphylococcal Infections/prevention & control , Surgical Wound Infection/drug therapy , Surgical Wound Infection/prevention & control , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Vancomycin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...